Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Most Shorted Stocks
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Investors
Private Companies
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Careers
Contact Us
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
MCP for Agents
Advertise with Us
Top Online Brokers
Gold IRA Companies
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Most Shorted Stocks
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Center
Investors
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Gold IRA Review
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
APRE
Stock Latest News
Company Announcements
Aprea Shareholders Approve Directors, Reverse Split Flexibility
20d ago
8K
APRE
Premium
Ratings
Pantginis Reiterates Buy on APR-1051 Developer, Keeps $1.20 Price Target After Encouraging ASCO Data and Superior Safety Profile
1M ago
APRE
Premium
Ratings
Analyst Reiterates Buy on Aprea as APR-1051 Data and Cash Runway Support Unchanged $5 Price Target
2M ago
APRE
Premium
The Fly
Aprea Therapeutics price target lowered to $6 from $7 at Wedbush
2M ago
APRE
Premium
The Fly
Aprea Therapeutics reports Q1 EPS (22c) vs. (66c) last year
2M ago
APRE
Premium
Company Announcements
Aprea Therapeutics Highlights Q1 2026 Results and Clinical Progress
2M ago
8K
APRE
Premium
The Fly
Oracle upgraded, Planet Fitness downgraded: Wall Street’s top analyst calls
2M ago
ABX
CNH
Premium
The Fly
Aprea Therapeutics initiated with an Outperform at Oppenheimer
2M ago
APRE
Premium
The Fly
Aprea Therapeutics files to sell 74.35M shares of common stock for holders
3M ago
APRE
Premium
Ratings
Aprea Therapeutics: Positive Read‑Through From Zentalis and Improving WEE1 Sentiment Support Buy Rating and $5 Target
3M ago
APRE
Premium
Company Announcements
Aprea Therapeutics Raises $30M to Advance Oncology Pipeline
3M ago
8K
APRE
Premium
The Fly
Aprea Therapeutics price target lowered to $1.20 from $4 at H.C. Wainwright
3M ago
APRE
Premium
Company Announcements
Aprea Therapeutics Announces $30 Million Private Placement
3M ago
8K
APRE
Premium
The Fly
Aprea Therapeutics confirms partial response in ongoing ACESOT-1051 trial
3M ago
APRE
Premium
Company Announcements
Aprea Highlights Early APR-1051 Data and Financial Update
4M ago
8K
APRE
Premium
The Fly
Aprea Therapeutics reports Q4 EPS (32c) vs. (49c) last year
4M ago
APRE
Premium
The Fly
Aprea Therapeutics sees cash runway into 1Q27
4M ago
APRE
Premium
The Fly
Aprea Therapeutics files to sell 12.58M shares of common stock for holders
5M ago
APRE
Premium
Ratings
Aprea Therapeutics: Emerging Dose-Responsive Efficacy and Favorable Safety of APR-1051 Underpin Buy Rating
5M ago
APRE
Premium
Company Announcements
Aprea Highlights Encouraging Phase 1 Data for APR-1051
5M ago
8K
APRE
Premium
The Fly
Aprea Therapeutics announces additional clinical activity for APR-1051
5M ago
APRE
Premium
The Fly
Aprea announces expansions of its global intellectual property estate
5M ago
APRE
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >
You need to enable JavaScript to run this app.
